Zongertinib-Hernexeos Dosage Specifications and Individualized Adjustment Suggestions

Zongertinib (trade name: Hernexeos) is an oral small molecule targeted drug, mainly used to treat patients with HER2 (ERBB 2) Patients with advanced or metastatic non-small cell lung cancer (NSCLC) with mutations in the tyrosine kinase domain (TKD). Recommended dosage is based on patient weight: patients weighing less than 90 kg should take 120 mg orally once daily; patients weighing 90 kg or more should take 180 mg orally once daily. Hernexeoscan be taken with or without food and is recommended to be continued until disease progression or intolerable toxicity occurs.

In terms of individualized adjustment, although the recommended dose is applicable to most patients, some patients may need to adjust the dose due to differences in age, liver and kidney function, concomitant diseases, or previous medication. For example, patients with impaired hepatic or renal function should carefully evaluate the need for dose reduction under the guidance of a physician to reduce the risk of drug accumulation and toxicity. At the same time, if the patient's weight is close to the 90kg cut-off, the doctor may determine the most suitable dose based on the overall physical condition and tolerance.

During the medication period, patients should regularly undergo hematology tests, liver and kidney function monitoring, and necessary electrocardiogram assessments to observe the body's tolerance to the medication. If moderate or severe adverse reactions occur (such as persistent nausea, significant decrease in platelets or white blood cells, severe rash, etc.), you should contact your doctor promptly and consider suspending the medication, reducing the dosage, or extending the dosing interval to ensure the safety of treatment.

In general, the dosage and usage of zongatinib (Hernexeos) emphasizes weight classification, taking it orally at a fixed time every day, with or without food, and continuing the drug until disease progression or unacceptable toxicity. At the same time, individualized dose adjustment, regular monitoring and timely treatment under the guidance of a doctor are important guarantees to ensure maximum drug efficacy and safety. Patients should choose formal channels to obtain drugs and strictly abide by medication regulations.

Reference link:https://www.drugs.com